Universities and Public Research Centres in the SORRISO network have expertise in the Research and Development of innovative materials. Their scientific and technical interplay contributes to achieving high standards of innovation and competitiveness in the field of applied bio-nanotechnologies.

Department of Neuroscience and Reproductive and Odontostomatological Sciences


The Department consists of many sections among which, those of Odontostomatological and Maxillofacial Science are involved in basic and clinical research programmes to study the interaction between cells, tissue and biomaterials, and the characterization of nanostructure surfaces for dentistry. These sections have a research laboratory of tissue engineering and biomaterials equipped with an atomic-force microscope, a device for computerized micro-tomographies and an area reserved for rapid prototyping.

Biostructures and Biosystems National Institute (I.N.B.B.) - Interuniversity Consortium


The Interuniversity Consortium “Istituto Nazionale Biostrutture e Biosistemi” (INBB – Biostructures and Biosystems National Institute) aims to promote and coordinate research and other scientific activities and applications in the field of Biostructures and Biosystems

UNISA Faculty of Engineering – Department Industrial Engineering


The research activity of the department focuses on the consolidation and innovation in industrial processing mainly for the food industry. Several research groups are involved in programmes funded by public and private grants to study: functional and structured polymeric materials, innovative chemical processes for the food industry and for energy and the environment.
The SORRISO network enterprises are pharmaceutical, nutraceutical and cosmetic companies. They have the expertise needed to setup and develop innovative product and process solutions in accordance with the market demands and the sustainability of the production chain.
New. Fa.Dem.: a pharmaceutical company producing a broad range of products such as medical products, galenic formulations, cosmetics and medical devices. The main product lines of New.Fa.Dem. can be grouped in 4 categories: i) prepackaged generic drugs and medications; ii) cosmetics; iii) galenic preparations; iv) medical devices
Elleva Pharma: is an Italian pharmaceutical group, operating in the research, development and marketing of pharmaceutical products and active ingredients. The company follows the entire drug supply chain: research and development, production, promotion and sales. The company, in particular, operates in a sector with high potential for development such as pharmaceuticals and nutraceuticals with a constantly growing in technology and innovation.
La.Fa.Re.: a chemical-pharmaceutical and biological industry. The company has achieved the expertise to establish itself in the pharmaceutical industry and develop technology transfer programmes with scientific and industrial partners.
Vantaggi by De Bortoli Europe was founded in 2010 with a clear mission: to develop products and solutions that make dental implant practice simple and safe, guaranteeing aesthetics and long-term functionality. The company operates in a sector with high development potential, such as dental medicine, with a constantly growing technological and innovation trend.
Valpharma: the company was founded in 2002 from the homonymous group Valpharma, a 35-year-old leading enterprise in the pharmaceutical industry. Given the high standards of expertise and competence, Valphama has achieved good results such as patent deposition to support their own technologies. This has allowed the company to develop more than 300 modified-release oral products, thus enhancing the presence on the global market and promoting partnerships with other companies, including multinational corporations.
Cosvitec: Promoted by the Ministry of Education, Universities and Research in support of Training programmes employing EU Structural Funds.
Progei Ricerca: was established with the aim of operating concretely in the fields of industrial research, technology transfer, industrialization, training and internationalization. The company's mission is to support the improvement of the industrial system (national and international) by the assistance to the use of the best financing opportunities as well as financial advice to companies, in particular in the field of facilitated finance and in the planning and management of extraordinary corporate finance operations.
Alfa Intes: a pharmaceutical company operating in ophthalmology both at national and international level. The company has its own laboratories destined for “research and development” in which molecules of pharmaceutical interest have been studied to address the challenges of innovation.
  • Discovery and isolation of new bioactive molecules from natural sources
  • Analysis of the potential benefits of bioactive molecules on human health
  • Design and development of innovative solutions to improve the bioavailability of molecules with poor pharmacokinetics
  • Identification of the most promising applicative context for the molecules and innovative solutions identified within the area of:
    • Pharmaceutics
    • Nutraceutics
    • Cosmetics
Siamo spiacenti, ma il contenuto è disponibile solo per gli utenti registrati.